Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhea

A. G. Boyle, K G Magdesian, R. Gallop, S. Sigdel, M. M. Durando

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Saccharomyces boulardii has been successfully used in the prevention and treatment of antimicrobial-associated diarrhoea in humans. We hypothesised that a viable, dried lyophilised preparation of S boulardii would survive in the gastrointestinal tract of horses with antimicrobial-associated enterocolitis, and significantly decrease the duration of diarrhoea. Twenty-one horses, over one year of age, with antimicrobial-associated diarrhoea of up to 72 hours duration, were consecutively randomised in a controlled prospective study. The treatment group received S boulardii (25 g, orally, every 12 hours) until the cessation of clinical signs. S boulardii was successfully cultured in 58.3 per cent of treatment horses on day 3. No statistically significant differences were found in days to return to normal faecal consistency; resolution of watery diarrhoea; return to normal heart rate, respiratory rate and temperature; resolution of leucopaenia; attitude improvement; appetite improvement; and survival at discharge. This is the first study to demonstrate survival of S boulardii in horses with gastrointestinal illness. Further study of the efficacy and safety of S boulardii in horses with antimicrobial-associated diarrhoea in a larger group is warranted.

Original languageEnglish (US)
Pages (from-to)128
Number of pages1
JournalVeterinary Record
Volume172
Issue number5
DOIs
StatePublished - Feb 2 2013

Fingerprint

Saccharomyces cerevisiae var. cerevisiae
Horses
Diarrhea
diarrhea
anti-infective agents
viability
horses
Enterocolitis
enterocolitis
leukopenia
duration
Survival
Leukopenia
Appetite
Respiratory Rate
appetite
respiratory rate
prospective studies
gastrointestinal system
Gastrointestinal Tract

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhea. / Boyle, A. G.; Magdesian, K G; Gallop, R.; Sigdel, S.; Durando, M. M.

In: Veterinary Record, Vol. 172, No. 5, 02.02.2013, p. 128.

Research output: Contribution to journalArticle

Boyle, A. G. ; Magdesian, K G ; Gallop, R. ; Sigdel, S. ; Durando, M. M. / Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhea. In: Veterinary Record. 2013 ; Vol. 172, No. 5. pp. 128.
@article{10b4cf3da70a4a02bf00d6cdf5c552dc,
title = "Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhea",
abstract = "Saccharomyces boulardii has been successfully used in the prevention and treatment of antimicrobial-associated diarrhoea in humans. We hypothesised that a viable, dried lyophilised preparation of S boulardii would survive in the gastrointestinal tract of horses with antimicrobial-associated enterocolitis, and significantly decrease the duration of diarrhoea. Twenty-one horses, over one year of age, with antimicrobial-associated diarrhoea of up to 72 hours duration, were consecutively randomised in a controlled prospective study. The treatment group received S boulardii (25 g, orally, every 12 hours) until the cessation of clinical signs. S boulardii was successfully cultured in 58.3 per cent of treatment horses on day 3. No statistically significant differences were found in days to return to normal faecal consistency; resolution of watery diarrhoea; return to normal heart rate, respiratory rate and temperature; resolution of leucopaenia; attitude improvement; appetite improvement; and survival at discharge. This is the first study to demonstrate survival of S boulardii in horses with gastrointestinal illness. Further study of the efficacy and safety of S boulardii in horses with antimicrobial-associated diarrhoea in a larger group is warranted.",
author = "Boyle, {A. G.} and Magdesian, {K G} and R. Gallop and S. Sigdel and Durando, {M. M.}",
year = "2013",
month = "2",
day = "2",
doi = "10.1136/vr.100833",
language = "English (US)",
volume = "172",
pages = "128",
journal = "Veterinary Record",
issn = "0042-4900",
publisher = "British Veterinary Association",
number = "5",

}

TY - JOUR

T1 - Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhea

AU - Boyle, A. G.

AU - Magdesian, K G

AU - Gallop, R.

AU - Sigdel, S.

AU - Durando, M. M.

PY - 2013/2/2

Y1 - 2013/2/2

N2 - Saccharomyces boulardii has been successfully used in the prevention and treatment of antimicrobial-associated diarrhoea in humans. We hypothesised that a viable, dried lyophilised preparation of S boulardii would survive in the gastrointestinal tract of horses with antimicrobial-associated enterocolitis, and significantly decrease the duration of diarrhoea. Twenty-one horses, over one year of age, with antimicrobial-associated diarrhoea of up to 72 hours duration, were consecutively randomised in a controlled prospective study. The treatment group received S boulardii (25 g, orally, every 12 hours) until the cessation of clinical signs. S boulardii was successfully cultured in 58.3 per cent of treatment horses on day 3. No statistically significant differences were found in days to return to normal faecal consistency; resolution of watery diarrhoea; return to normal heart rate, respiratory rate and temperature; resolution of leucopaenia; attitude improvement; appetite improvement; and survival at discharge. This is the first study to demonstrate survival of S boulardii in horses with gastrointestinal illness. Further study of the efficacy and safety of S boulardii in horses with antimicrobial-associated diarrhoea in a larger group is warranted.

AB - Saccharomyces boulardii has been successfully used in the prevention and treatment of antimicrobial-associated diarrhoea in humans. We hypothesised that a viable, dried lyophilised preparation of S boulardii would survive in the gastrointestinal tract of horses with antimicrobial-associated enterocolitis, and significantly decrease the duration of diarrhoea. Twenty-one horses, over one year of age, with antimicrobial-associated diarrhoea of up to 72 hours duration, were consecutively randomised in a controlled prospective study. The treatment group received S boulardii (25 g, orally, every 12 hours) until the cessation of clinical signs. S boulardii was successfully cultured in 58.3 per cent of treatment horses on day 3. No statistically significant differences were found in days to return to normal faecal consistency; resolution of watery diarrhoea; return to normal heart rate, respiratory rate and temperature; resolution of leucopaenia; attitude improvement; appetite improvement; and survival at discharge. This is the first study to demonstrate survival of S boulardii in horses with gastrointestinal illness. Further study of the efficacy and safety of S boulardii in horses with antimicrobial-associated diarrhoea in a larger group is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84874070314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874070314&partnerID=8YFLogxK

U2 - 10.1136/vr.100833

DO - 10.1136/vr.100833

M3 - Article

VL - 172

SP - 128

JO - Veterinary Record

JF - Veterinary Record

SN - 0042-4900

IS - 5

ER -